TWO · 4127.TWO
Tien Liang BioTech Co., Ltd.
NT$34.85-NT$1.95 (-5.3%)
Tien Liang BioTech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 63.7% below the high.
Loading market information…
TWO · 6935.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 06:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Prince Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Prince Pharmaceutical Co., Ltd.’s forward annual dividend is NT$0.25 per share, paid annual. The forward yield is 0.92% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
THE COMPANY BEHIND THE TICKER
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$34.85-NT$1.95 (-5.3%)
Tien Liang BioTech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 63.7% below the high.
NT$31.45-NT$0.05 (-0.16%)
NeoCore Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.91% below the high.
NT$71.70+NT$0.20 (+0.28%)
Puriblood Medical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.48% below the high.
NT$22.55-NT$0.35 (-1.53%)
Bio Preventive Medicine Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.98% below the high.
NT$19.70-NT$0.60 (-2.96%)
Anxo Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.57% below the high.
NT$23.00NT$0.00 (0.0%)
LabTurbo Biotech Corporation’s quoted price sits in the lower half of its reported 52-week range, 11.88% below the high.
NT$23.20-NT$0.50 (-2.11%)
Excelsior Biopharma Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.06% below the high.
NT$24.00NT$0.00 (0.0%)
Wiltrom Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.66% below the high.
